Buffalo, New York – Reichert Technologies® is pleased to introduce the all-new Phoroptor VRx Virtual Live Demo Experience. The Virtual Live Demo allows a Reichert specialist to conduct a Phoroptor VRx Digital Refraction System demonstration via a live, one-on-one video conferencing feed.

Explore the benefits of having a Phoroptor VRx Digital Refraction System from the comfort of your home or office at a time that fits your schedule. With the Phoroptor VRx Virtual Live Demo, we are able to demonstrate all the system components, including the Phoroptor VRx head, Phoroptor VRx controller, and the ClearChart® 4 Digital Acuity System.

Phoroptor VRx sets new standards in digital refraction. With the thinnest, most compact design available, incredibly fast lens exchanges, motorized prisms, split cylinder lenses, and ultra-quiet operation, Phoroptor VRx offers an outstanding user and patient experience. Phoroptor VRx also wirelessly connects to EMR systems as well as numerous models of pre-test and acuity devices from both Reichert and other manufacturers, for effortless integration.

To book your Phoroptor VRx Virtual Live Demo, or learn more about the new demo capabilities, visit reichert.com/demovrx

About Reichert Technologies®
Reichert Technologies®, based out of Buffalo, New York, is a global leader in designing, engineering, and manufacturing high-quality diagnostic devices and equipment for ophthalmologists, optometrists, opticians, and retail eye centers.

Inventor of Phoroptor®, Lensometer®, and the Non-Contact Tonometer, Reichert continues a 180 year tradition of providing American innovation with the digital Phoroptor® VRx, Tono-Pen® Tonometer, ClearChart® Digital Acuity Systems, and Ocular Response Analyzer®, a break-through in glaucoma diagnosis and management, featuring Corneal Hysteresis and IOPcc.

Reichert Technologies® is a business unit of the Ultra Precision Technologies Division of AMETEK, Inc. a leading global manufacturer of electronic instruments and electromechanical devices with annual sales of approximately $5 billion.